Drawing for AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE

USPTO serial 85270345

AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
MADDEN, ANNE
Law office
TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marilyn F. Kelly

Marilyn F. Kelly Bristol-Myers Squibb Company345 Park AvenueTrademark DepartmentNew York, NY 10154

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human useACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2011MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Jun 30, 2011ABN1ABANDONMENT - EXPRESS MAILED
Jun 29, 2011EXARTEAS EXPRESS ABANDONMENT RECEIVED
Jun 22, 2011CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2011DOCKASSIGNED TO EXAMINER
Apr 19, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 23, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2011NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance